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 Methods associated with increased risk of self-harm repetition were minor and severe self-
cutting, intentional drug overdoses (IDOs) involving multiple drugs including psychotropic 
drugs and self-harm by blunt object.  
 Minor self-cutting was the method associated with highest repetition risk. 
 Repetition risk was similar following IDOs of four or more drugs involving psychotropic 
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Abstract 
Background: Risk of self-harm repetition has consistently been shown to be higher following self-
cutting compared to intentional drug overdose (IDO) and other self-harm methods. The utility of 
previous evidence is limited due to the large heterogeneous method categories studied. This study 
examined risk of hospital presented self-harm repetition according to specific characteristics of self-
harm methods. 
Methods: Data on consecutive self-harm presentations to hospital emergency departments (2010-
2016) were obtained from the National Self-Harm Registry Ireland. Associations between self-harm 
method and repetition were analysed using survival analyses.   
Results: Overall, 65,690 self-harm presentations were made involving 46,661 individuals. Self-harm 
methods associated with increased repetition risk included minor self-cutting, severe self-cutting, 
multiple drug IDOs involving psychotropic drugs and self-harm by blunt object. Minor self-cutting 
was the method associated with highest repetition risk (adjusted hazard ratio (AHR) 1.38, 95% CI 
1.31-1.45). Risk of repetition was comparable following IDOs of four or more drugs involving 
psychotropic drugs (AHR=1.29, 95 % CI 1.20-1.39), severe self-cutting (AHR 1.25, 95% CI 1.16-1.34) 
and blunt object (AHR=1.23, 95% CI 1.07-1.42).  
Limitations: Information was not available on suicide or other causes of mortality.  
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Conclusions: Self-harm method and the associated risk of repetition should form a core part of 
biopsychosocial assessments and should inform follow-up care for self-harm patients. The observed 
differences in repetition associated with specific characteristics of IDO underline the importance of 
safety planning and monitoring prescribing for people who have engaged in IDO. 
 






Self-harm is one of the strongest risk factors for both non-fatal self-harm repetition and suicide 
(Carroll et al., 2014; Chan et al., 2016; Larkin et al., 2014b).  The individual, societal and economic 
cost associated with self-harm is significant and increases with repetition (Sinclair et al., 2011). To 
aid clinicians in planning treatment and follow-up, it is important to understand the factors that are 
associated with increased risk of self-harm repetition (Health Service Executive, 2017; NICE, 2004, 
2011). Method of self-harm has been widely investigated as a risk factor for repetition and self-
cutting is the only method consistently associated with repeated self-harm (Larkin et al., 2014b). The 
utility of the evidence emerging from research examining self-harm method as a risk factor for 
repetition is limited because methods are classified into large heterogeneous groups, most 
commonly intentional drug overdose (IDO) and self-poisoning combined and self-cutting (Bergen et 
al., 2010; Birtwistle et al., 2017; Lilley et al., 2008). More detailed examination of self-harm methods 
has the potential to enhance our understanding of their relationship with non-fatal repetition 
(Birtwistle et al., 2017).    
Intentional drug overdose (IDO) is the most common method of hospital presented self-harm, 
involved in more than two thirds of presentations (Arensman et al., 2018; Geulayov et al., 2016; 
Perry et al., 2012). Previous studies reported lower risk of self-harm repetition following IDO 
compared to self-cutting and similar risk compared to other types of self-injury (Bergen et al., 2010; 
Birtwistle et al., 2017; Lilley et al., 2008; Perry et al., 2012). However, episodes of IDO are not 
homogeneous in terms of clinical characteristics and medical severity. Increased number of tablets 
and multiple drugs taken in IDO are associated with higher levels of suicidal intent (Haw et al., 2015; 
















Kinoshita, 2016; Neeleman and Wessely, 1997). Specific characteristics of IDOs have been largely 
overlooked in large scale prospective studies of self-harm. One study, conducted over 20 years ago, 
found that ingestion of more than one drug was associated with increased risk of IDO repetition 
(Owens et al., 1994). In addition, use of benzodiazepines in IDO has been found to be a significant 
predictor of short term risk of repetition (Cooper et al., 2006).  
Self-cutting is involved in approximately 20% of self-harm presentations to hospital (Birtwistle et al., 
2017; Hawton et al., 2007; Perry et al., 2012). Hospital presentations resulting from self-cutting can 
vary widely in terms of injury severity (Larkin et al., 2014a). So far, only one study has examined the 
severity of self-cutting and repetition of self-harm observing that increased severity was associated 
with reduced self-harm repetition overall but the authors noted an increased risk of repetition using 
high lethality methods (Larkin et al., 2014a). The relationship between repetition risk and self-cutting 
severity has not been examined in comparison with any other self-harm methods. Other methods of 
self-harm, such as attempted hanging, attempted drowning and self-harm with a blunt object, have 
received little individual consideration in relation to risk of non-fatal repetition.  
Within this context, the present study examined the risk of self-harm repetition according to the 
characteristics of self-harm method(s) involved in an index self-harm presentation using national 



















Setting and sample 
The National Self-Harm Registry Ireland (NSHRI) collects data on consecutive patients who present to 
EDs as a consequence of self-harm. Since 2006, the NSHRI has full national coverage of all 36 acute 
hospitals in Ireland.  
The NSHRI uses the following definition of self-harm ‘an act with non-fatal outcome in which an 
individual deliberately initiates a non-habitual behaviour, that without intervention from others will 
cause self-harm, or deliberately ingests a substance in excess of the prescribed or generally 
recognised therapeutic dosage, and which is aimed at realising changes that the person desires via 
the actual or expected physical consequences’ (Platt et al., 1992). The definition includes acts 
involving varying levels of suicidal intent and various underlying motives. Presentations involving 
acts without intention to self-harm, including accidental overdoses of medication, street drugs or 
alcohol, are not recorded in the NSHRI. All self-harm presentations to the ED are included in the 
NSHRI data irrespective of whether the presentation results in hospital admission. More information 
on data collection and quality assurance has been reported elsewhere (Perry et al., 2012).  
Analyses were conducted for presentations recorded between 1 January 2010 and 31 December 
2016. The dataset were restricted to individuals who did not present to hospital with self-harm 
during 2007-2009, in order to maximise the number of true first presentations after 1 January 2010. 
A similar method was used by Perry et al. (2012). All repeat presentations, rather than first repeat 
presentations only, were included in the analyses with each repeat presentation becoming an index 
presentation. 
Data items 
Data Registration Officers (DROs) collect data on self-harm presentations according to standardised 
methods of case ascertainment and definition. The following core data items routinely collected by 
the DROs were accessed: demographic characteristics (age and sex), method(s) of self-harm, alcohol 
involvement. Self-harm repetition was defined as a presentation to an ED as a result of a self-harm 
act following an index self-harm presentation at any time during the 7-year study period. All 
repeated self-harm presentations were included in the definition of self-harm repetition irrespective 
of method involved in the repeat act. Encrypted patient initials, sex and date of birth were used to 
differentiate between self-harm patients and to identify repeat presentations by the same patients. 
Self-harm presentations by the same individual occurring on the same day were recorded once to 
















presentation in the 3 years prior to the study period were included in the analyses. The study 
examined all presentations (including first and repeat presentations) as index presentations using 
repeat event analysis. Self-harm history reflected the number of presentations an individual had 
prior to an index presentation during the study period.   
Method of self-harm was recorded according to the Tenth Revision of the WHO’s International 
Classification of Diseases (ICD-10) codes for intentional injury (World Health Organization, 2008). 
IDO was defined as the intentional ingestion of more than the prescribed or recommended dose of 
any drug, as well as IDO of illegal drugs (ICD codes X60-X64). IDO was categorised according to 
patient-reported number of tablets, number of drugs and class of drugs taken. Categories of drug 
class were psychotropic drugs, analgesic drugs and other prescription or over-the-counter drugs. 
Psychotropic drugs included: minor tranquilisers, major tranquilisers, barbiturates/anti-epileptic 
drugs, antidepressants, and other mood stabilisers. Analgesic drugs included: paracetamol, opiates, 
salicylates, non-steroidal anti-inflammatory drugs (NSAIDs).  Analgesic and opiate drug groups 
include compound drugs. Self-poisoning was defined as the ingestion of substances other than 
drugs, including organic solvents, pesticides, gases and other noxious substances, with non-
ingestible chemical substances (ICD codes X66-X69). Self-cutting severity was operationalised 
according to treatment received. Minor self-cutting included injuries that required no treatment, 
wound cleaning or steri-strips only while severe self-cutting included injuries that required sutures 
or plastic surgery referral. Self-harm by blunt object (ICD code X79) included self-battery and head-
banging. Analyses were based on method involvement rather than primary or sole method. Where 
multiple methods were involved in a self-harm presentation, up to 5 methods were recorded. 
Statistical analyses  
Cox proportional hazard models were fitted to estimate time to self-harm repetition according to 
the following method variables: number of tablets, number of drugs and class of drugs taken in IDO, 
self-cutting severity, blunt object, attempted hanging, attempted drowning, self-poisoning with non-
ingestible substances, jumping from a height, crashing a motor vehicle and lying or jumping in front 
of a moving object.  To analyse multiple methods involved in each presentation, methods were 
included in analyses as separate variables with “all other methods” as the reference category. 
Number of tablets, number of drugs, and class of drugs taken in IDO were examined separately in 
univariate models. To avoid collinearity, these characteristics of IDOs were entered as a combined 
variables in multivariate models (number of drugs / number of tablets and number of drugs / class of 
drugs)  The following co-variates were included in the multivariate model: sex, age, alcohol 
















CI) were calculated. To further illustrate the findings, Kaplan-Meier curves were plotted, truncated at 
24 months.  
Follow-up time after an index self-harm presentation varied depending on the point during the study 
period when the presentation occurred due to the fixed final date, 31 December 2016, ranging from 
1 day to 7 years. Variable length of follow-up was accounted for in the analyses. The study used 
repeat event analyses in that all repeat presentations, were included in the analyses with each 
repeat presentation becoming an index presentation. Lack of independence of observations 
between presentations made by the same individual was adjusted for by using robust analyses that 
modified the variance of estimates.  
Nelson Aalen graphical tests showed reasonably parallel lines indicating that the assumption of 
proportional hazards was upheld. The assumption was tested using post-estimation statistics on the 
basis of Schoenfeld residuals (Grambsch and Therneau, 1994). The post estimation statistics were 
statistically significant for some variables. However, Spearman’s Rho coefficients were small (ranging 
from .015 to .057) indicating little violation of the proportional hazards assumption. Analyses were 
carried out using SPSS 22 and Stata 12 for Windows. 
Ethics statement  
Ethical approval for the NSHRI was granted by the National Research Ethics Committee of the Faculty 
of Public Health Medicine. Ethical approval was also received from the relevant hospital or Health 



















A total of 65,690 self-harm presentations by 46,661 individuals were made to hospital EDs in Ireland 
from 2010 to 2016 (Table 1). The majority of presentations (41.3%) were made by patients in the 25-
44 year age range (mean age=32.7, SD±14.4). 53.4% of presentations involved females. The most 
common self-harm method was IDO (68.3%) followed by self-cutting (23.8%), attempted hanging 
(6.6%) and attempted drowning (3.0%) (Table 1). IDO was more common among females (74.8% vs 
60.9%, p<0.001). All other methods examined were more common among males (p<0.001): self-
cutting (26.2% vs 21.7%), attempted hanging (10.0% vs 3.6%), attempted drowning (3.9% vs 2.3%), 
self-poisoning (2.4% vs 1.7%), jumping from a height (1.7% vs 0.9%), blunt object (1.1% vs 0.1%), 
jumping from a moving object (0.9% vs 0.5%) and crashing a motor vehicle (0.6% vs 0.3%). 
Approximately half of IDOs involved one drug (53.8%) and 46.8% involved less than 30 tablets. 
Psychotropic drugs were the most common drug class, involved in 45.2% of IDOs.  Most self-cutting 
presentations were minor self-cutting (66.0%).  
Self-harm repetition  
During the seven years follow-up, 29.0% of episodes were followed by a repeat self-harm 
presentation. The median number of repeat presentations was two (interquartile range±1).   
Self-cutting  
Incidence of repetition was highest following self-cutting compared to all other methods (36.1% vs 
26.7% respectively; χ2=18.3, p<.001). Repetition occurred following 37.7% of minor and 35.2% of 
severe self-cutting presentations (Table 1). Self-harm repetition was more frequent and occurred 
earlier following minor compared to severe self-cutting (Figure 1a). In adjusted survival analysis, 
both minor (AHR 1.38, 95% CI 1.31-1.46) and severe self-cutting were predictive of self-harm 
repetition (AHR 1.25, 95% CI 1.16-1.34) (Table 2). Minor self-cutting was associated with higher risk 
of repetition compared to severe-self-cutting (AHR 1.11 95% CI 1.03-1.20, p=0.007).  
Intentional drug overdose  
Overall, incidence of repetition was lower following IDO compared to non-IDO presentations (27.7% 
vs 31.7% respectively; χ2=111.4, p<.001). A repeat self-harm episode occurred following 26.3% of 
IDOs that involved a single drug only. Repetition was more likely following multiple drug IDOs. A 
subsequent self-harm presentation occurred following 32.9% of IDOs of four or more drugs (Table 
1). Approximately 26% of IDOs involving less than 30 tablets were followed by a repeat self-harm 
presentation while approximately 30% of IDOs of 30 or more tablets were followed by a repeat 
















compared to analgesic drugs (30.1% vs 25.1% respectively) (Table 1). The relationships between self-
harm repetition and the specific types of psychotropic and analgesic drugs are presented in detail in 
Supplementary Table 1.  The Kaplan-Meier curves (Figure 1b, 1c and 1d) show the cumulative 
probability of a repeated self-harm presentation in the 24-month period after an index IDO 
presentation. Figure 1b illustrates that repetition risk following IDO increased with each additional 
drug taken. The curves in Figure 1c highlight a pattern of earlier and more frequent repetition 
following IDOs of 30 or more tablets compared to those involving less than 30 tablets.  Figure 1d 
demonstrates higher repetition risk following IDOs involving psychotropic drugs compared to non-
psychotropic IDOs.  
In adjusted survival analysis, with number of drugs and class of drug combined, multiple drug IDOs 
involving psychotropic drugs were associated with increased risk compared to single drug IDOs that 
did not involve psychotropic drugs. IDOs involving four or more drugs, at least one of which was a 
psychotropic drug, were associated with 29.3% increased risk of repetition (AHR=1.29, 95 % CI 1.20-
1.39). In further adjusted survival analysis, when combined with number of drugs taken, number of 
tablets taken did not contribute substantially to repetition risk (Supplementary Table 2). 
Other Methods 
Incidence of repetition was higher after an episode of self-harm by blunt object compared to other 
self-harm methods (34.8% vs 28.9% respectively; χ2=9.9, p=.002) (Table 1). Repetition was 
significantly lower following self-poisoning compared to other methods (23.7% vs 29.1% 
respectively; χ2=18.3, p<.001) and crashing a motor vehicle compared to other methods (19.8% vs 
29.01% respectively; χ2=11.3, p<.001). In adjusted survival analysis, self-harm by blunt object was an 
independent predictor of self-harm repetition, associated with a 23.3% increase in risk compared to 
presentations not involving a blunt object (AHR=1.23, 95% CI 1.07-1.42) (Table 2). Self-poisoning was 


















Sex, age and self-harm history 
There were no significant sex differences in incidence or risk of self-harm repetition (Table 1 and 2). 
28.8% of males and 29.1% of females repeated. When risk of repetition was examined separately by 
sex, the relationship between self-harm method and repetition was broadly similar (Supplementary 
Table 3). However, there were some minor differences. In adjusted survival analyses, attempted 
hanging and jumping in front of a moving object were associated with increased risk of repetition 
among females but not males (Supplementary Table 3).  
Repetition was most likely in the 25-44 years age group (30.6% repeated) and least common among 
those aged 65 or older (14.3% repeated) (Table 1). In adjusted survival analyses, compared to the 
25-44 group, repetition was 41.5% less likely in the 65 or older age group (AHR 0.59 95% CI 0.51-
0.67) and 6.1% less likely in the 45-64 age group (AHR 0.94 95% CI 0.89-0.99) (Table 2). Overall, risk 
of repetition was highest among those aged less than 15 years with an increased risk of 17.0% 
compared to those aged 25-44 years (AHR 1.17 95% CI 1.07-1.28). Consistent with the overall 
findings, females in the <15 years age group had the highest risk of repetition; however, males aged 
15-24 years were the age group with the highest risk of repetition (Supplementary Table 3).  
Repetition risk was significantly higher among patients who had at least one previous self-harm 
presentation (Table 1 and 2). Repetition risk increased with each additional previous self-harm 
presentation, with the highest risk following presentations among those with a history of four or 
more previous presentations (AHR 8.93, 95% CI 8.26-9.63). Figure 2 shows the proportion of repeat 
self-harm presentations by number and class of drug taken in IDO, severity of self-cutting and 
previous self-harm history. The graph highlights the overlap in incidence of repetition following self-
cutting and IDOs that involved at least four drugs, including psychotropic drugs, a pattern that 
remained consistent as the number of previous self-harm presentations increased. Figure 2 also 



















This study provides the largest, most in-depth study of the association between method of self-harm 
and risk of non-fatal repetition using nationally representative data from hospital EDs. Self-harm 
methods associated with increased repetition risk included minor self-cutting, severe self-cutting, 
multiple drug IDOs that involved psychotropic drugs and self-harm by blunt object. Minor self-
cutting was associated with the highest risk of repetition. Repetition risk was comparable following 
severe self-cutting, IDOs of four or more drugs that involved psychotropic drugs and self-harm by 
blunt object. Findings in relation to previous studies 
We found that the relationship between repetition risk and IDO varied according to number and 
class of drugs taken. When psychotropic drugs were taken in IDO, involvement of multiple drugs was 
associated with increased risk of repeated self-harm compared to single drug IDOs. This builds on 
the findings of one previous study of hospital presented IDO which reported that risk of IDO 
repetition was higher among those who had taken more than one drug (Owens et al., 1994). 
Consistent with our findings, a previous UK-based study identified benzodiazepines, one of the most 
common psychotropic drugs used in IDO (Daly et al., 2018; Geulayov et al., 2016), as a significant 
predictor of short term repetition (Cooper et al., 2006). Psychotropic drug involvement in IDO is 
more common among those who are in receipt of a prescription for these drugs and in contact with 
psychiatric services (Corcoran et al., 2013; Tournier et al., 2009). Psychiatric treatment at the time of 
a self-harm episode is associated with increased risk of subsequent repetition (Larkin et al., 2014b).  
IDO is frequently considered a method associated with lower risk of continued self-harm compared 
to self-cutting (Bergen et al., 2010; Birtwistle et al., 2017; Lilley et al., 2008; Perry et al., 2012). 
Overall, we found that incidence of repetition following IDO was significantly lower than self-cutting. 
However, the previously accepted disparity in repetition risk between self-cutting and IDO was not 
evident when IDO was categorised according to number of drugs and class of drug taken and self-
cutting categorised according to severity. In our study, repetition risk was similar following IDOs of 
four or more drugs that involved psychotropic drugs and severe self-cutting, which has not been 
addressed by previous studies. These findings indicate that IDO should not be treated as a 
homogeneous category when considering the method used in relation to the assessment of risk in a 
clinical setting. This is further supported by the fact that multiple drug IDOs and increased number of 
tablets are associated with higher suicidal intent (Haw et al., 2015; Townsend et al., 2001), severe 
medical outcomes (Hori and Kinoshita, 2016; Neeleman and Wessely, 1997) and subsequent suicide 
















Minor self-cutting was the method associated with highest risk of subsequent repetition. This finding 
compliments a previous study that reported higher risk of repetition following self-cutting requiring 
little or no treatment compared to self-cutting requiring more extensive medical intervention (Larkin 
et al., 2014a). Larkin et al. observed that use of lethal methods in repeat self-harm was associated 
with severity of self-cutting (Larkin et al., 2014a). If this potential escalation in method lethality 
resulted in an increase in fatal outcomes from self-harm acts that followed severe self-cutting, this 
may partly explain the reduction in overall repetition risk associated with severe compared to minor 
self-cutting. However, this has not been examined in previous studies. Differences in future risk 
according to cutting severity may also be influenced by differences in assessment and treatment 
(Larkin et al., 2014a). Patients who are admitted to hospital are more likely to receive a psychosocial 
assessment compared to those who are discharged directly from the ED (Lilley et al., 2008). Those 
with more extensive injuries as a result of self-cutting may be more likely to be admitted, which 
could increase the likelihood of receiving a psychosocial assessment which is associated with 
reduced risk of self-harm (Bergen et al., 2010).  
Self-harm by blunt object was associated with increased risk of repetition. This is a novel finding as 
repetition following self-harm by blunt object has not been independently examined previously. 
These findings indicate that, consistent with minor self-cutting, this method of self-injury is 
associated with ongoing distress despite the likelihood that the resulting physical injuries require 
minimal medical treatment. However, it is important to note that this self-harm method is relatively 
uncommon, involved in just 1% of presentations in this sample. Overall other self-harm methods, 
including attempted hanging, attempted drowning, self-poisoning, jumping from a height, crashing a 
motor vehicle and jumping in front of a moving object, were not associated with increased 
repetition risk. The relationship between these methods and non-fatal repetition has received little 
individual consideration in previous studies. The absence of repetition risk following these methods 
should not be considered reflective of a profile of reduced risk as they are associated with high 
lethality (Mergl et al., 2015) and increased risk of subsequent suicide (Bergen et al., 2012; Runeson 
et al., 2010). Among females, there was some evidence of an increased risk of repetition following 
two of the high lethality methods, jumping in front of a moving object and attempted hanging, which 
are less common among females compared to males (Mergl et al., 2015). Previous research has 
found that involvement of lethal methods in a self-harm episode increases risk of subsequent suicide 
among males but not females (Skogman et al., 2004). Furthermore, method-specific lethality is 
higher among males (Mergl et al., 2015). Thus, it is possible that males who engaged in high lethality 
















increased risk of non-fatal repetition associated with two high lethality methods among females but 

















Strengths and limitations 
This study used data from a national surveillance system including all self-harm presentations to 
hospital EDs over a seven-year period. The large sample size allowed for the examination of risk 
factors for self-harm repetition that have received limited attention in previous research. Due to the 
complete national coverage of hospital-presented self-harm, loss at follow-up was minimised. 
Analyses were limited to individuals with no self-harm presentation in the 3 years prior to the study 
period to maximise the likelihood that  first patient presentations included in the analyses were first 
ever presentations. This reduces the potential for results to be biased by lack of information on self-
harm history. All repeat presentations, rather than first repeat presentations only, were examined in 
the sample to avoid an underestimation of repetition (Lilley et al., 2008). However, because 
individuals commonly switch methods of self-harm from one episode to the next, results from 
analyses using repeat event analysis need to be interpreted with care (Birtwistle et al., 2017; Owens 
et al., 2015). There were some limitations to the study. This study focuses on hospital cases of self-
harm only. Therefore, findings cannot be generalised to self-harm repetition not resulting in a 
hospital presentation. A further limitation relates to missing data: number of tablets taken in IDO 
and treatment for self-cutting were not recorded in a substantial proportion of presentations (28.7% 
and 12.1% respectively) as the variables were not always recorded in the case notes. Furthermore, 
information on toxicology of IDOs was not available. Consequently, data on drugs taken and quantity 
of tablets taken was based on self-report. In addition, information is not available from the NSHRI on 
drugs prescribed to the patient at the time of the IDO. It was, therefore, not possible to examine the 
impact of access to certain drugs and involvement in IDO. Finally, information on suicide or other 
causes of mortality is not recorded by the NSHRI. Therefore, cases will have been included in the 
analyses that should have been censored due to loss of life. As risk of suicide differs according to 
method of previous non-fatal self-harm (Bergen et al., 2012; Runeson et al., 2010), it is likely that 
this will have influenced our results.   
Implications 
This study found that non-fatal self-harm repetition differs according to specific characteristics of the 
index self-harm method(s). This highlights that detailed consideration of method of self-harm should 
form a routine part of psychosocial assessment and management of risk and need for self-harm 
patients.  
Previous research has found that hospital care following self-harm presentations to hospital varies 
depending on the method used, where self-cutting patients were less likely to receive a psychosocial 
















healthcare staff (Taylor et al., 2009) and may conceivably contribute to less than optimal experience 
of care. Minor self-cutting and self-harm by blunt object were identified as significant predictors of 
repetition. This highlights the necessity for assessment and intervention even if the injuries 
sustained require little or no medical treatment (Larkin et al., 2014a; Lilley et al., 2008) as they are 
likely to recur. The study also identified increased severity of self-cutting, a method characteristic 
previously associated with high lethality repeat presentations (Larkin et al., 2014a), as a predictor of 
repetition. There is a need for staff educational initiatives and care pathways for plastics surgery 
services to ensure that all such presentations receive a timely psychosocial assessment. 
Consideration should also be given to mental health service provision of enhanced follow-up for self-
cutting presentations that require sutures or plastics intervention. 
International guidelines highlight the critical role that clinicians’ prescribing practices play in self-
harm management and suicide prevention (NICE, 2004, 2011; World Health Organization, 2014). The 
increased repetition risk associated with multiple drug IDOs in our sample underline the importance 
of monitoring the availability of multiple drugs, particularly to patients prescribed psychotropic 
drugs. Furthermore, due to the potential dangers associated with some psychotropic drugs, care 
should be taken where possible to prescribe drugs that are least toxic in IDO (NICE, 2004, 2011). 
Ongoing awareness training with clinicians may be beneficial to reduce inappropriate prescribing of 
drugs commonly used in IDO that are associated with increased risk of repetition (World Health 
Organization, 2014). Limiting the duration/amount of medication prescribed and dispensed for self-
harm patients should be considered as a matter of routine. Collaboration with carers to reduce 
availability of and access to other medication at home should be a routine part of safety planning. 
A word of caution is that due to the frequency of method switching between presentations (Owens 
et al., 2015), characteristics of self-harm method alone should never be used as static predictors of 
subsequent repetition. We found that risk of repeated self-harm was high irrespective of the 
method and a person’s risk increased substantially with each repeat presentation. All presentations 
following self-harm regardless of method, should receive a standard of assessment and care that 
includes standardised triage, bio-psycho-social assessment, access to skilled clinicians, involvement 
of family/carers, emergency care plans and appropriate follow-up (Health Service Executive, 2017; 
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Figure 1. Kaplan-Meier failure curves showing the cumulative probability of a repeated self-harm 
presentation. The curves show the cumulative probability of a repeated self-harm presentation in 
the 24 month period after an index self-harm presentation. Variation in the probability of a repeated 
self-harm presentation is shown by severity of self-cutting (A) by number of drugs taken in 
intentional drug overdose (IDO) (B) by number of tablets taken in IDO (C) and by the class of drug 






0 3 6 9 12 15 18 21 24
Time to SH (months)






0 3 6 9 12 15 18 21 24
Time to SH (months)






0 3 6 9 12 15 18 21 24
Time to SH (months)






0 3 6 9 12 15 18 21 24
Time to SH (months)






0 3 6 9 12 15 18 21 24
Time to SH (months)






0 3 6 9 12 15 18 21 24
Time to SH (months)






0 3 6 9 12 15 18 21 24
Time to SH (months)






0 3 6 9 12 15 18 21 24
Time to SH (months)





0 3 6 9 12 15 18 21 24
Time to SH (months)






0 3 6 9 12 15 18 21 24
Time to SH (months)






0 3 6 9 12 15 18 21 24
Time to SH (months)






0 3 6 9 12 15 18 21 24
Time to SH (months)






0 3 6 9 12 15 18 21 24
Time to SH (months)






0 3 6 9 12 15 18 21 24
Time to SH (months)






0 3 6 9 12 15 18 21 24
Time to SH (months)






0 3 6 9 12 15 18 21 24
Time to SH (months)
Kaplan-Meier  f ailure est imat es
A B 
C D 





Time to self-harm (months) Time to self-harm (months) 



























Number of drugs taken in IDO 
Severe  
Minor  
Unknow                     
severity 
Severity of self-cutting 





































Figure 2. Proportion of repeat presentations in the 24 month period after an index self-harm 
presentation. Proportion is shown by number and class of drugs taken in IDO, severity of self-cutting 
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Table 1 Characteristics of all self-harm presentations and repeat presentations, 2010-2016 and Cox 






Univariate Cox proportional 
hazard survival analysis 
n % n % Hazard ratio (95% CI) p 
All presentations 65,690 100 19,029 29.0   
Intentional drug overdose (IDO) (X60-X64) 44,890 31.7 12,433 27.7 0.83 (0.79-0.87) <0.001 
Number of drugs taken in IDO (X60-X64)       
1 drugs taken  24,130 36.7 6,335 26.3 0.78 (0.74-0.82) <0.001 
2 drugs taken 11,038 16.8 3,122 28.3 0.84 (0.79-0.89) <0.001 
3 drugs taken 5,756 8.8 1,675 29.1 0.87 (0.81-0.93) <0.001 
4+ drugs taken 3,960 6.0 1,301 32.9 1.00 (0.92-1.08) 0.971 
Drug class(s) taken in IDO       
Psychotropic  25,260 38.5 7,600 30.1 0.90 (0.69-0.77) <0.001 
Analgesic 18,830 28.7  7,706 25.1 0.74 (0.70-0.78) <0.001 
Other  11,803       18.0 3,231 27.4 0.82 (0.78-0.87) <0.001 
Number of tablets taken in IDO(X60-X64)       
<10 tablets 5,221 8.0 1,342 25.7 0.75 (0.70-0.81) <0.001 
10-19 tablets  9,012 13.7 2,335 25.9 0.77 (0.72-0.82) <0.001 
20-29 tablets 6,777 10.3 1,797 26.5 0.78 (0.73-0.83) <0.001 
30-39 tablets 3,700 5.6 1,094 29.6 0.89 (0.82-0.92) 0.003 
40-49 tablets 2,460 3.7 769 31.3 0.95 (0.87-1.03) 0.215 
50-59 tablets 1,462 2.2 437 29.9 0.91 (0.81-1.02) 0.100 
60-69 tablets 1,080 1.6 331 30.7 0.92 (0.82-1.04) 0.179 
70-79 tablets 594 0.9 175 29.5 0.87 (0.75-1.02) 0.096 
80 tablets+ 1,721 2.6 510 29.6 0.88 (0.79-0.98) 0.018 
Unknown quantity of tablets 12,863 19.6 3,643 28.3 0.86 (0.81-0.90) <0.001 
Self-cutting (X78) 15,616 23.8 5,638 36.1 1.50 (1.42-1.58) <0.001 
Severity of self-cutting (X78)       
Minor self-cutting 10,309 15.7 3,886 37.7 1.62 (1.52-1.72) <0.001 
Severe self-cutting  3,414 5.2 1,202 35.2 1.41 (1.30-1.53) <0.001 
Unknown severity self-cutting 1,893 2.9 551 29.1 1.07 (0.94-1.23) 0.318 
Attempted hanging (X70) 4,335 6.6 1,199 27.7 0.96 (0.89-1.02) 0.165 
Attempted drowning (X71) 1,967 3.0 553 28.1 0.97 (0.88-1.06) 0.499 
Self-poisoning (X66-69) 1,329 2.02 315 23.7 0.79 (0.70-0.89) <0.001 
Jumping from a height (X81) 818 1.25 208 25.4 0.88 (0.77-1.02) 0.087 
Blunt object (X79) 601 0.9 209 34.8 1.36 (1.16-1.59) <0.001 
Jumping in front of moving object (X81) 456 0.7 144 31.6 1.23(1.04-1.47) 0.049 
Crashing motor vehicle (X82) 273 0.4 54 19.8 0.65 (0.50-0.85) 0.001 
Alcohol involved 23,160 35.3 6,661 28.8 0.95 (0.91-0.99) 0.021 
Sex       
Male 30,597 46.6 8,824 28.8 1  
Female 35,093 53.4 10,205 29.1 1.01 (0.95-1.08) 0.319 
Age       
<15yrs 2,201 3.35  599 27.2 0.91 (0.80-1.02) 0.103 
15-24 yrs 22,094 33.6 6,365 28.8 0.95 (0.88-1.01) 0.095 
25-44 yrs 27,094 41.3 8,276 30.6 1  
45-64 yrs 12,536 19.1 3,537 28.2 0.911 (0.84-0.99) 0.020 
65+yrs 1,765 2.7 252 14.3 0.434 (0.36-0.52) <0.001 
Self-harm history       
No previous presentations 46,661 71.0 9,166 19.6 1  
1 previous presentation 9,166 14.0 3,591 39.2 2.46 (2.37-2.56) <0.001 
2 previous presentations 3,591 5.5 1,809 50.4 3.69 (3.51-3.88) <0.001 
3 previous presentations 1,809 2.8 1,058 58.5 4.91 (4.61-5.23) <0.001 
















Note:. For each method of self-harm variable, the reference category is all presentations not involving that 
method. Repeated self-harm percentages represent the proportion of those who represented to hospital as a 
















Table 2 Multivariate Cox proportional hazard survival analyses for time to subsequent self-harm 
repetition during 2010–2016. 
Variables 
Total 
Hazard ratio  
(95% CI) 
p 
Number of drugs taken and class of 
drug taken in intentional drug 
overdose (IDO) (X60-X64) 
  
No psychotropic, 2 drugs 0.94 (0.88-1.02) 0.135 
No psychotropic, 3 drugs 0.78 (0.69-0.88) <0.001 
No psychotropic, 4 drugs 0.95 (0.81-1.11) 0.493 
Psychotropic, 1 drug 1.06 (1.01-1.12) 0.024 
Psychotropic, 2 drugs 1.15 (1.09-1.22) <0.001 
Psychotropic, 3 drugs 1.17 (1.10-1.25) <0.001 
Psychotropic, 4 drugs 1.29 (1.20-1.39) <0.001 
Self-cutting (X78)   
Minor self-cutting 1.38 (1.31-1.45) <0.001 
Severe self-cutting  1.25 (1.16-1.34) <0.001 
Unknown severity self-cutting 1.10 (0.99-1.22) 0.086 
Attempted hanging (X70) 1.04 (0.98-1.11) 0.223 
Attempted drowning (X71) 1.01 (0.93-1.10) 0.809 
Self-poisoning (X66-69) 0.85 (0.76-0.96) 0.007 
Jumping from a height (X81) 0.93 (0.81-1.07) 0.298 
Blunt object (X79) 1.23 (1.07-1.42) 0.003 
Jumping in front of moving object 
(X81) 1.13 (0.95-1.33) 0.162 
Crashing motor vehicle (X82) 0.87 (0.66-1.13) 0.298 
Alcohol involved 0.96 (0.93-1.00) 0.031 
Sex (female) 1.01 (0.97-1.05) 0.723 
Age   
<15yrs 1.17 (1.07-1.28) <0.001 
15-24yrs 1.00 (0.95-1.04) 0.843 
25-44yrs 1  
45-64yrs 0.94 (0.89-0.99) 0.016 
65+yrs 0.58 (0.51-0.67) <0.001 
Previous self-harm presentations   
1 previous presentation 2.39 (2.30-2.49) <0.001 
2 previous presentations 3.55 (3.37-3.73) <0.001 
3 previous presentations 4.69 (4.39-5.00) <0.001 
4+ previous presentations 8.93 (8.26-9.63) <0.001 
Note: For all method of self-harm variables, the reference category is ‘no psychotropic, 1 drug’ IDO. 
 
